Development
Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 14.35M | 35.95M | 36.28M | 6.13M | -15.80M |
| Total Depreciation and Amortization | 39.17M | 36.85M | 36.65M | 33.17M | 36.34M |
| Total Amortization of Deferred Charges | -- | -- | -- | 4.25M | -- |
| Total Other Non-Cash Items | 13.86M | -2.09M | 5.42M | 39.46M | 21.71M |
| Change in Net Operating Assets | -15.52M | -9.20M | -56.88M | 57.56M | 12.04M |
| Cash from Operations | 51.86M | 61.51M | 21.47M | 140.56M | 54.28M |
| Capital Expenditure | -27.24M | -44.75M | -50.51M | -56.94M | -38.67M |
| Sale of Property, Plant, and Equipment | 2.62M | 877.00K | 26.00K | 7.03M | 130.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 681.00K | 2.04M | -6.99M | -41.73M | 1.06M |
| Cash from Investing | -23.94M | -41.84M | -57.47M | -91.64M | -37.48M |
| Total Debt Issued | -31.10M | -96.00K | 539.00M | 18.32M | 39.71M |
| Total Debt Repaid | -6.28M | -5.88M | -409.55M | -54.17M | -6.63M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | -30.00M | -- | -10.00M | -- |
| Other Financing Activities | -14.86M | -16.44M | -13.77M | -22.54M | -26.18M |
| Cash from Financing | -52.25M | -52.42M | 115.68M | -68.38M | 6.91M |
| Foreign Exchange rate Adjustments | -252.00K | -1.44M | -3.44M | 1.36M | -565.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.59M | -34.19M | 76.24M | -18.10M | 23.14M |